Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-7706621 |
Trade Name | |
Synonyms | |
Drug Descriptions |
JNJ-7706621 is a dual inhibitor of CDK1/2 and AURKA, B, which induces cell cycle arrest (PMID: 16204078, PMID: 31850205). |
DrugClasses | Aurka Inhibitors 27 Aurkb Inhibitors 21 CDK1 Inhibitor 13 CDK2 Inhibitor 31 |
CAS Registry Number | 443797-96-4 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Fulvestrant + JNJ-7706621 | Fulvestrant JNJ-7706621 | 0 | 0 |
JNJ-7706621 | JNJ-7706621 | 0 | 0 |